Select Medical Holdings Corp (SEM) FinancialsSEMSelect Medical Holdings Corp

Select Medical Holdings Corp (SEM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Non-Medicar, accounting for 59.2% of total sales, equivalent to $842.05M. Other significant revenue streams include Medicare and Other revenues. Understanding this composition is critical for investors evaluating how SEM navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Select Medical Holdings Corp maintains a gross margin of 9.69%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.92%, while the net margin is 4.49%. These profitability ratios, combined with a Return on Equity (ROE) of 7.49%, provide a clear picture of how effectively SEM converts its operational activities into shareholder value.

In the context of the broader market, SEM competes directly with industry leaders such as SGRY and ARDT. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, SEM's gross margin of 9.69% stands against SGRY's 17.78% and ARDT's 55.77%. Such benchmarking helps identify whether Select Medical Holdings Corp is trading at a premium or discount relative to its financial performance.

No financial data available for analysis.